Announcements Trials
Browse Landscape

Phase

Phase 2 47Phase 1 21Phase 1/2 5Phase 3 4Phase NA 2

Status

Active not recruiting 11Recruiting 5Completed 4Terminated 3Not yet recruiting 2Withdrawn 1

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 2Thoracic 1Gastrointestinal 1

Conditions

Prostatic Neoplasms 1Pain 1Liver Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1

Interventions

Cyclophosphamide 299Cisplatin 298Paclitaxel 257Radiotherapy 255Fluorouracil 234Carboplatin 234Docetaxel 230Doxorubicin 216Dexamethasone 166Gemcitabine 156Vincristine 147Etoposide 136Leucovorin 133Capecitabine 129Bevacizumab 129Prednisone 125Rituximab 118Methotrexate 118Cytarabine 110Filgrastim 99Trastuzumab 97Oxaliplatin 96pembrolizumab 83Pemetrexed 73Epirubicin 70Tamoxifen 69Drug Therapy 69Irinotecan 65Granulocyte Colony-Stimulating Factor 60Daunorubicin 58

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Completed × cabozantinib × Clear all
NCT04471428 2025-12-22

CONTACT-01

Hoffmann-La Roche

Phase 3 Completed
366 enrolled 24 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01908426 2021-05-06

CELESTIAL

Exelixis

Phase 3 Completed
707 enrolled 20 charts 1 FDA
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT01865747 2021-04-27

METEOR

Exelixis

Phase 3 Completed
658 enrolled 15 charts
Genitourinary

Carcinoma, Renal Cell

NCT01605227 2018-03-14

COMET-1

Exelixis

Phase 3 Completed
1,028 enrolled 18 charts
Genitourinary

Pain, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡